Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
MainRexult study aims to carefully evaluate a cohort of patients with schizophrenia and related disorder prescribed with the combination therapy with Abilify Maintena and Rexulti on its efficacy and tolerability in a real-life clinical setting.
Epistemonikos ID: 4b2cffbb6a793c120a55bd905ac6b7994f3d14d5
First added on: May 09, 2024